Related Experiment Video
Updated: Jul 13, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer
Angela Papageorgiou1, Colin P N Dinney, David J McConkey
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
Apoptosis induced by interferon-alpha (IFNalpha) is associated with induction of TRAIL in a number of different cell types. Here we examined whether or not TRAIL was required for apoptosis in a model human bladder cancer cell line (UM-UC-12) and defined the molecular mechanisms involved in IFNalpha-induced TRAIL expression. Exposure to IFNalpha resulted in concentration-dependent induction of TRAIL and apoptosis. Inhibition of TRAIL or downstream components of the TRAIL cell death pathway (FADD, caspase-8) via siRNA-mediated knockdown attenuated IFNalpha-induced cell death, thereby implicating TRAIL in the response. IFNalpha induced rapid STAT-1 phosphorylation and DNA binding activity and subsequent accumulation of IRF-1. Transfection with siRNAs directed against STAT-1 or IRF-1 inhibited IFNalpha-induced TRAIL production and cell death, and chromatin immunprecipitation (ChIP) analyses demonstrated that IFNalpha induced direct, time-dependent binding of both transcription factors to the TRAIL promoter. Together, our results demonstrate that IFNalpha induces TRAIL expression via a STAT-1/IRF-1-dependent mechanism in human bladder cancer cells, and this induction of TRAIL plays an important role in IFNalpha-induced cell killing.
Insights
Interferon-alpha (IFNalpha) triggers apoptosis in bladder cancer cells by upregulating TRAIL. This process relies on STAT-1 and IRF-1 transcription factors, highlighting a key mechanism for IFNalpha-induced cell death.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Interferon-alpha (IFNalpha) induces apoptosis in various cell types, often via TRAIL.
- The role of TRAIL in IFNalpha-mediated apoptosis in human bladder cancer cells was previously unclear.
Purpose of the Study:
- To investigate if TRAIL is essential for IFNalpha-induced apoptosis in human bladder cancer cells (UM-UC-12).
- To elucidate the molecular mechanisms underlying IFNalpha-induced TRAIL expression.
Main Methods:
- Cell treatment with IFNalpha and TRAIL pathway inhibitors.
- siRNA-mediated knockdown of TRAIL, FADD, caspase-8, STAT-1, and IRF-1.
- Analysis of STAT-1 phosphorylation, DNA binding activity, and IRF-1 accumulation.
- Chromatin immunoprecipitation (ChIP) assays to assess transcription factor binding to the TRAIL promoter.
Main Results:
- IFNalpha induced concentration-dependent TRAIL expression and apoptosis in UM-UC-12 cells.
- Inhibition of TRAIL or downstream signaling components (FADD, caspase-8) reduced IFNalpha-induced cell death.
- IFNalpha rapidly activated STAT-1 and IRF-1, which were crucial for TRAIL induction and apoptosis.
- STAT-1 and IRF-1 directly bound to the TRAIL promoter upon IFNalpha stimulation.
Conclusions:
- TRAIL is a critical mediator of IFNalpha-induced apoptosis in human bladder cancer cells.
- IFNalpha activates TRAIL expression through a STAT-1 and IRF-1 dependent pathway.
- This mechanism provides insight into the anti-cancer effects of IFNalpha in bladder cancer.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
